恒指跌幅扩至逾460点考验26,400 石药(01093.HK)续挫8%
美国总统特朗普昨日正式签署涉港法案,遭到中方猛烈抨击并警告美方要纠正错误,否则会作出反制措施。市场忧虑会影响中美达成首阶段贸易协议。恒指继昨天(期结日)反覆回软後,今早低开188点或0.7%,跌幅持续扩至465点或1.7%,报26,428,大幅跑输区内;成交额159亿元。
蓝筹股无一幸免,跌幅普遍逾1%-2%,其中重磅股腾讯(00700.HK)及友邦(01299.HK)低见331.6元及78.55元,现造332.6元及78.85元,跌1.6%及1.7%,前者失守10天及百天线,後者失守20天线。
出口股万洲(00288.HK)、吉利(00175.HK)、恒安(0144.HK)、中信股份(00267.HK)、长实集团(01113.HK)、中海外(00688.HK)、联通(00762.HK)、碧桂园(02007.HK)、金沙(01928.HK)、中海油(00883.HK)、国寿(02628.HK)、交行(3328.HK)、瑞声(02018.HK)及舜宇(02382.HK)更跌逾2%-3%,後者最伤报127.4元。
内地公布医保药品名单,新增70个药品平均降价60.7%,石药(01093.HK)更续挫8%报18.16元,股价失守50天线;中生(01177.HK)三连跌,报10.36元,续跌2.4%。
深成及沪指继昨天续跌0.3%-0.5%後,现造2,878及9,585,续跌0.4%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.